Hightower Clinical is conducting a study to evaluate an investigational treatment for individuals with heart failure with preserved or mildly reduced ejection fraction and obesity. The trial aims to determine whether the treatment can reduce heart-related complications, such as cardiovascular death and hospitalizations.